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Abstract: Manipulation of host cellular processes by translocated bacterial effectors is key to the
success of bacterial pathogens and some symbionts. Therefore, a comprehensive understanding of
effectors is of critical importance to understand infection biology. It has become increasingly clear
that the identification of host protein targets contributes invaluable knowledge to the characterization
of effector function during pathogenesis. Recent advances in mapping protein–protein interaction
networks by means of mass spectrometry-based interactomics have enabled the identification of host
targets at large-scale. In this review, we highlight mass spectrometry-driven proteomics strategies
and recent advances to elucidate type-III secretion system effector–host protein–protein interactions.
Furthermore, we highlight approaches for defining spatial and temporal effector–host interactions,
and discuss possible avenues for studying natively delivered effectors in the context of infection.
Overall, the knowledge gained when unravelling effector complexation with host factors will provide
novel opportunities to control infectious disease outcomes.
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1. Introduction
1.1. Effectors and Their Role in Establishing Host Interactions
For thousands of years, the coevolutionary arms race between bacteria and their hosts have
provided opportunities for adaptations of bacteria–host associations. As a first line of defense,
hosts have evolved to recognize molecular patterns of microbial origin, such as flagellin or
lipopolysaccharide (LPS). These elicitors are termed either microbe-associated molecular patterns
(MAMPs) or pathogen-associated molecular patterns (PAMPs). Since these terms are frequently
used interchangeably, we will maintain the broader term MAMP [1]. MAMPs are detected by
pattern recognition receptors (PRRs) that induce various antimicrobial and immune responses to
eliminate encroaching infective agents, referred to as MAMP-triggered immunity (MTI) [2,3]. In turn,
pathogenic and symbiotic bacteria have mastered powerful strategies to deceive these host immune
surveillance systems to promote their own survival and dissemination. Part of their tactic consists of
introducing a batch of virulence factors—termed “effectors”—into the host cell. The emergence of
these host-injected bacterial effectors has in turn led to host responses recognizing and counteracting
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these effectors, leading to effector-triggered immunity (ETI), which often involves programmed
cell death [2,4,5]. Although first discovered in plants, the ETI response has more recently been
shown to also exist in mammalian cells [5]. Highly evolved pathogens, such as Legionella, Salmonella,
Pseudomonas, and Ralstonia spp., or symbionts, such as Rhizobium spp., have further expanded their
effector repertoire to suppress ETI or use it to their own benefit. For most of these bacteria, the injection
of effectors has become essential for their association with the host. For instance, the acquisition
of specific effector proteins by nonpathogenic Escherichia coli (E. coli) has led to the evolution of
different “pathotypes”, such as enterohaemorrhagic E. coli (EHEC) and enteropathogenic E. coli (EPEC),
pathotypes with high disease burden [6]. In a similar fashion, Ralstonia solanacearum mutants lacking
the transcriptional activator HrpB, which controls expression of the type-III secretion system (T3SS)
and effectors, show a reduced colonization, infection and multiplication ability in planta [7]. Strikingly,
for certain pathogens such as Chlamydiae, up to 10% of the coding sequences encode secreted effectors,
i.e., ~90 out of ~900 proteins, underpinning their importance in the pathogen’s life cycle [8].
1.2. Delivery of Protein Effectors by Specialized Secretion Systems
Although Gram-positives, such as Listeria monocytogenes, typically achieve effector release via
general secretion pathways, in Gram-negatives, translocation of effectors into the host cell is facilitated by
specialized evolved bacterial secretion systems. Nine different secretion systems have been discovered
thus far [9], of which secretion system type-III, IV and VI (T3SS, T4SS and T6SS) provide a mean for the
direct delivery of effector proteins into target cells that can be of either prokaryotic or eukaryotic origin.
Many Gram-negative animal and plant pathogens (e.g., EHEC/EPEC, Chlamydia, and Salmonella spp.,
Ralstonia spp. and Pseudomonas syringae (P. syringae)) employ the T3SS, also referred to as “injectisome”.
In recent years, exciting progress on the assembly, structure, and function of this molecular syringe has
been made, as extensively reviewed in [10]. The T3SS was found to be evolutionarily related to the
flagellar apparatus [11]. More specifically, this sophisticated 3.5 megadalton syringe-like system is
composed of a cytosolic sorting complex that acts as the effector receiving component, several inner
and outer membrane-embedded structures, a hollow needle spanning the three membranes upon host
cell infection and the translocon complex at the tip (Figure 1) [12,13]. In contrast, the type IV secretion
system (T4SS) is structurally related to the DNA conjugation system and can transport single proteins,
protein complexes, or protein-DNA complexes into the prokaryotic or eukaryotic host cell. The type VI
secretion system (T6SS) used by numerous Gram-negative bacterial species on the other hand, shares
structural homology to phage tails and can, besides their primary function in antibacterial antagonism
by means of secreted substrates, also secrete proteins into eukaryotic host cells. Gram-negative bacteria
interacting with eukaryotic hosts most often harbor the T3SS. Although the technologies discussed
in this review are in principle applicable to study effector–host protein–protein interactions (EH-PPIs)
of all the above-mentioned secretion systems, we will mainly focus on type-III effectors (T3Es) and
T3SS-related infection biology.
1.3. Effectors: Their Origin and Mechanisms of Action
As opposed to the highly conserved T3SS machinery [9], T3Es are functionally and structurally
diverse [10]. As a safety net for adaptations in the host, a remarkably high degree of functional
redundancy is common among T3Es, and is the product of continuous acquisition, modification and
terminal reassortment of effector genes [11]. In terminal reassortment, new effectors arise as a result of
genome rearrangements, e.g., the addition of an existing secretion domain to an existing gene [14].
Variations and adaptations to the effector repertoire of the pathogen or symbiont facilitate an intra- or
extracellular lifestyle, distinct host ranges, and changes in pathogenicity. For instance, acquisition of
large regions in the bacterial genome involved in pathogenicity, termed pathogenicity islands (PAIs),
serve typical hallmarks of important host adaptations. This is illustrated by the establishment of an
intracellular lifestyle of Salmonella upon acquisition of a second Salmonella pathogenicity island (SPI-2)
through horizontal gene transfer in combination with an exquisite temporal expression control of
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both SPI-1 and -2 encoded proteins [15]. Furthermore, an in silico analysis of the genomes of multiple
Ralstonia solanacearum (R. solanacearum) strains revealed that strains capable of infecting tomato plants
possess two additional effectors (RipS3 and RipH3) compared to tomato nonpathogenic strains [16].
Indeed, the triple deletion mutant ripH1-3 is significantly impaired in tomato pathogenicity [17],
which demonstrates the involvement of effectors in shaping host range.
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Figure 1. The type-III secretion system delivers bacterial effectors into the host cell by acting as
a molecular syringe. Chaperones (CHs) are believed to keep type-III effectors (T3Es) in a partially
unfolded state inside the bacterium. CHs are released from the T3Es at the sorting platform and are
brought into the hollow channel of the needle filament for subsequent release inside the host cell
cytoplasm. IM = inner membrane; PG = peptidoglycan; OM = outer membrane.
In contrast to bacterial proteins post-translationally transported through the general secretion (Sec)
or twin-arginine translocation (Tat) dependent universal pathways, T3Es typically lack a conserved
cleavable secretion signal [18], but possess an intrinsically disordered N-terminal ~20 amino acid long
sequence enriched for serine, threonine, isoleucine and proline residues [19–21] and often a downstream
20 to 50 amino acid long chaperone-binding domain (CBD) [22]. Newly synthesized T3Es are generally
believed to be kept in a partially unfolded state by chaperones that also target them to the T3SS
sorting platform [10,23]. Only upon contact with the host, hierarchical secretion of the effectors by
an ATP and proton-motive force-driven secretion mechanism through the T3SS is fully engaged.
More specifically, at the sorting platform, effector proteins are stripped of their chaperones and further
unfolded through ATPase activity, enabling their successive passage through the 20 Å hollow needle of
the T3SS (Figure 1) [24]. Subsequent cytosolic delivery of the effectors in the host cell prompts folding
into their active protein conformation. Although T3Es are thought to remain in an unfolded and thus
inactive state inside bacteria, markedly, very recently, intra-bacterial enzymatic glycosylation activity
of the C. rodentium non-LEE (locus of enterocyte effacement)-encoded effector NleB was demonstrated,
which challenges the envisioned idea of T3Es residing dormant inside the pathogen [25].
Once inside the host cell, the effector operates by interacting with one or more host proteins.
Diverse activities are ascribed to T3Es—sharing the common objective of modulating the host
to the needs of the bacterium. In a controlled and integrated fashion, (sets of) effectors modify
cytoskeletal dynamics, transcription, translation and signal transduction at multiple levels by
covalent modification or binding of host protein targets, or by mimicking activities of host cell
proteins among others. For instance, the phosphoinositide phosphatase activities of effectors
IpgD (Inositol phosphate phosphatase D) and SopB (Salmonella outer protein B; also known as
SigD) from Shigella and Salmonella spp., respectively, enzymatically modify plasma membrane
phosphoinositides [26–28]. Alteration of the phosphoinositide composition of the plasma membrane
causes membrane ruffling and actin cytoskeleton rearrangements in the host cell. Other representative
examples include the actin-binding Salmonella effectors SipA/SspA (Salmonella invasion protein
A/stringent starvation protein A) and SipC/SspC that reshape the actin cytoskeleton of the host by
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stimulating actin polymerization [29,30], and the phytopathogen R. solanacearum GalNAc-T activation
(GALA) effectors that mimic plant E3 ubiquitin ligases to interact with SKP1-like proteins [31,32].
Also, in the context of beneficial interactions, effectors may play a key role. For example, the effector
gene ErnA (effector required for nodulation-A) is conserved across many bradyrhizobia strains and
triggers nodule formation in plants, as inoculation with the mutant results in loss of nodule formation.
To properly achieve these functions, bacterial effectors are predicted to practice so-called “structural
imperfect mimicry” in which a delicate balance between infectivity and toxicity has to be found [33].
By imperfectly simulating eukaryotic interaction interfaces, effectors can discriminate bacterial from
host origin and steer their effects accordingly.
1.4. The Past and Future Ways of Studying Effector Interactomes
In the past few decades, examination EH-PPIs has largely relied on binary yeast two-hybrid
(Y2H) screenings that entail the heterologous expression of a genetically tagged bait and prey protein
in yeast, and using yeast survival as a readout [34]. The scalability and low cost of Y2H enabled semi
high-throughput screening of prey libraries, such as the host target screens reported in the case of
phytopathogens P. syringae and Hyaloperonospora arabidopsidis effectors probing a library of roughly
8000 Arabidopsis proteins [35] and for mapping of the EHEC host-pathogen interactome [36]. In the
former study, Y2H screening showed that some host proteins, referred to as proteins hubs, often involved
in immunity, are targeted by multiple effectors from evolutionary distant pathogens. Most of the
interactions (33/51) found in Y2H between the effectors and the extensively targeted plant protein
TCP14 were validated in planta [37]. To date, Y2H remains a popular screening platform for plant-based
research, which can be coupled to next-generation sequencing (NGS), dubbed Y2H-sequencing
(Y2H-seq), to further improve sensitivity and increase scalability [38]. Representative studies in which
Y2H-seq was applied to study EH-PPIs include the identification of interactors of the HopZ2
(Hrp-dependent outer protein Z2) T3E from P. syringae implicated in plant host colonization [39] and
the large-scale Y2H-screening for mapping interactions between effectors from the plant vascular
pathogens R. solanacearum and X. campestris and A. thaliana protein [40]. However, high rates of false
negative and positive interactions have been reported in Y2H-screens due to the non-physiological
interaction conditions [41]. Recent advances in mass spectrometry (MS)-based proteomics strategies
have unlocked opportunities for high-throughput and sensitive detection of EH-PPIs. In this review,
we discuss the state-of-the-art MS-based toolbox for elucidating effector–host interactions and elaborate
on the latest advances and shortcomings when studying EH-PPIs.
2. Methods to Elucidate Effector–Host Protein–Protein Interactions
2.1. Affinity- or Immune-Based Purification of Effector Interactomes in a Host Context
Reminiscent to Y2H being a predecessor of binary PPI approaches, affinity purification (AP)
followed by MS (AP-MS) can be considered to be the founding MS-based approach for studying PPIs and
protein co-complexation (reviewed in [42]). AP-MS consists of the expression of a translational fusion of
the protein of interest (e.g., bait) to an affinity tag and consecutive co-purification of its interactors from
native cell lysates by means of antibodies against the affinity tag (Figure 2), followed by proteolytic
digestion of the sample (e.g., trypsin) which is subsequently subjected to MS [43]. By combining the
separation capability of liquid chromatography (LC) with the analytic power of MS it has become
a common practice to separate digests before sample injection into the mass spectrometer. By the online
coupling of LC separation with MS, dubbed “LC-MS”, the overall sample complexity can be reduced,
thereby providing a more comprehensive proteome coverage following MS-based analysis. AP can be
done in a single or double step, depending on the selected (composite) affinity tag—of which diverse
options exist, such as the FLAG-, HA- (i.e., hemagglutinin antigenic peptide), or tandem AP (TAP)-tag.
In case of tagged bait expression, either high transfection efficiency models for overexpression of the
fusion protein or, more ideal and gaining more interest in recent years, models expressing baits at
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endogenous levels can be used for carrying out AP-MS studies. In a similar fashion, immunopurification
(IP) followed by MS (IP-MS) enables the co-purification of interactors of untagged baits by using
antibodies specific for the selected bait protein. Unfortunately, weak and transient interactions are
commonly missed in AP- and IP-MS (i.e., false negatives), viewing the loss of spatial organization upon
cell lysis. Chemical crosslinking of proximal amino acids reactive side chains has emerged in recent
years to surmount these problems [44], but has not been widely adopted in the field of effector–host
interactions. Challenges with artefact integration, MS-spectra interpretation, and defining streamlined
MS data analysis workflows likely accounts for the latter observation. False positive interactions, on the
other hand, can be limited in AP-MS by use of appropriate reference controls, the use of an inducible
expression system or the use of endogenous tagging. Another drawback intrinsic to the purification
strategies used for AP- and IP-MS is the vast underrepresentation of membrane proteins, mainly
because of the challenge to extract and solubilize these while maintaining physiological interactions
during the purification process. Nevertheless, AP-MS has clearly proven of value for the identification
of strong and less dynamic PPIs, or interactions enduring the applied lysis conditions, and the method
is commonly used as reference method when asserting new PPI screening methods.
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cell lysis by the genetic fusion of a bait to the myristoylated (zigzag line) human immunodeficiency 
virus type 1 (HIV-1) GAG protein. Expression of the fusion protein elicits the aggregation of the GAG 
portion at the plasma membrane, enabling the budding of virus-like particles (VLPs) and “trapping” 
of host preys inside VLPs. Anti-FLAG purification of the VLPs in the culture medium is followed by 
MS-based analysis of the VLP content (c). BioID; In BioID, the genetic fusion of a protein biotin ligase 
(BL) to a protein of interest, or bait (B), results in the in vivo biotinylation of interacting prey (P) 
proteins that are captured after lysis via streptavidin-based purification for subsequent MS-based 
analysis. Purple circles represent biotin. 
Classical AP-MS data only provides a static view of protein complexes. To facilitate the study of 
dynamic and regulated interactions, quantitative proteomics approaches have been implemented 
easing MS data interpretation and analysis. Metabolic protein labeling (e.g., stable isotope labeling of 
amino acids in cell culture (SILAC)) can be used to quantify relative differences in protein levels 
among light and heavy stable isotope-labeled samples (Figure 3) [45]. In case of SILAC, cells are 
differentially grown in medium containing either regular amino acids or amino acids (usually 
arginine or lysine) enriched with heavy carbon-13 (13C) and/or nitrogen-15 (15N) atoms, i.e., 
isotopologs. Consequently, the proteomes matching distinct experimental conditions are mass 
encoded when pooled, thus enabling the MS-based determination of (differences in) relative protein 
abundances (of interactors). When SILAC is coupled with IP, the protein lysates of the differentially 
SILAC-labeled cell populations undergo IP specific to the (tagged) bait protein (ectopically) 
Figure 2. Complementary MS-based co-co plex platforms to capture protein–protein interactions.
(a) AP-MS; In AP-MS, the b rotein (B) is fused to an epitope tag (T) that as a high affinity
to an i mobilized antibody. The bai interactome (P1-P3) is co-purified after native cell lysis and
subsequ ntly identified through mass s ctr etry (MS). (b) Virotrap; Virotrap omits the need for
cell lysis by the genetic fusion of a bait to the yristoylated (zigzag line) human immunodeficiency
virus type 1 (HIV-1) GAG protein. Expression of the fusion protein elicits the aggregation of the GAG
portion at the plasma membrane, enabling the budding of virus-like particles (VLPs) and “trapping”
of host preys inside VLPs. Anti-FLAG purification of the VLPs in the culture medium is followed
by MS-based analysis of the VLP content (c). BioID; In BioID, the genetic fusion of a protein biotin
ligase (BL) to a protein of interest, or bait (B), results in the in vivo biotinylation of interacting prey
(P) proteins that are captured after lysis via streptavidin-based purification for subsequent MS-based
analysis. Purple circles represent biotin.
Classical AP-MS data only provides a static view of protein complexes. To facilitate the study
of dynamic an regulated interactions, quantitative proteomics approaches have be n implemented
easing MS data interpreta ion and analysis. Metabolic protein labeling (e.g., stable isotope ab ling of
amino acids in cell culture (SILAC)) can be use to quantify relative differences in protein levels among
light and heavy stable isotope-labeled samples (Figure 3) [45]. In case of SILAC, cells are differentially
grown in medium containing either regular amino acids or amino acids (usually arginine or lysine)
enriched with heavy carbon-13 (13C) and/or nitrogen-15 (15N) atoms, i.e., isotopologs. Consequently,
the proteomes matching distinct experimental conditions are mass encoded when pooled, thus enabling
the MS-based determination of (differences in) relative protein abundances (of interactors). When SILAC
is coupled with IP, the protein lysates of the differentially SILAC-labeled cell populations undergo
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IP specific to the (tagged) bait protein (ectopically) expressed, added recombinantly, or—in case of
effector biology—delivered in the context of a host-microbe interaction in a differentially SILAC labeled
sample. In this way, relative differences in eluate protein levels can be determined by differential
MS-based analysis, thereby pointing to potential interactors of the effector under study (Figure 3).
SILAC is rarely used in planta due to the autotrophic nature of plants and thus poor metabolic labeling
efficiency, although some efforts have been made (reviewed in [46]). Rather, plant researchers rely
on post-metabolic labeling strategies or alternatively, label-free quantification (LFQ) for comparative
quantitative proteomics.
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Figure 3. Defining protein interactions using stable isotope labeling of amino acids in cell culture
(SILAC)-based quantitative mass spectrometry. In the representative example shown, SILAC comprises
differential metabolic labeling (light and heavy stable isotope-labeled samples) of proteins in distinct
experimental conditions (− and + effector expression/delivery, in case of the light and heavy SILAC
sample, respectively), followed by mixing of the resulting proteomes and a subsequent affinity-
or immunopurification (AP/IP) step targeting the effector bait (B). After digestion of the resulting
mixed protein sample, relative protein abundances, and concomitantly, specific effector interactors
(significantly enriched as heavy label; P1-P3) can easily be distinguished from contaminants by
MS-based analysis. RI = relative intensity.
Besides enabling the extensive mapping of protein complexes in various models in general [42]
(e.g., the use of TAP in Sacch romyces cerevisiae [47]), AP-MS has lso significantly contr buted to the
elucidation of EH-PPIs in bacterial infection biology (Table 1), such as in the large-scale identification
of host interactors of Chlamydia trachomatis (C. trachomatis) vacuolar membrane protein (Inc) T3Es [48].
Mirrashidi et al. transiently expressed 58 Incs in human HEK293T cells and subjected them to
large-scale AP-MS analysis, revealing 354 high-confidence Inc-host interactors [48]. Interestingly,
the comprehensive EH-PPI dataset showed significant overlap with human host targets of viral proteins,
suggesting shared pathogenic strategies for obligate intracellular microorganisms. This observation
is further in line with a recent report in which a plant virus-encoded protein as well as the GALA1
and GALA3 R. solanacearum effectors convergently evolved to target chlor plast , thereby interfering
with salicylic acid (SA)-mediated defense [49]. Fur her research proved that IncE binding to sorting
nexins (SNXs) 5/6 relocated them to the inclusio membrane. This observati n was followed up by
comparing the AP-MS interaction profiles of wild-type versus SNX5 mutated at the IncE binding surface,
overall leading to the discovery that IncE disrupts a native interaction between cation-independent
mannose-6-phosphate receptor (CI-MPR) and SNX5 and thus most likely represents an example of host
mimicry [50]. Sontag et al. made use of AP-MS and came up with a collection of high-confident EH-PPIs
of eight Salmonella and four Citrobacter effectors [51]. Interestingly, while for some Salmonella enterica
serovar Typhimurium (STm) effectors, e.g., GtgA and SseI, 25, and 14 confident EH-PPIs, respectively,
were retrieved, for four other effectors (CigR, PipB2, SifA, and SssA) no host interactors were found.
In contrast, D’Costa and colleagues screened five Salmonella T3Es, including PipB2 and SifA, for human
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protein interactors using AP-MS in a cellular context (i.e., by the use stable epithelial cell lines and
inducible effector expression), and identified a total of 130 putative EH-PPIs (including 63 EH-PPIs for
PipB2 and 13 EH-PPIs for SifA) [52]. The observation that SifA and PipB2 localizations are steered
by specific protein targeting mechanisms such as prenylation [53] and lipid raft-recruitment [54],
respectively might (partially) account for the success of identifying EH-PPIs of these effectors in a cellular
context. Recently, 9 and 12 STm effectors were screened using (crosslinking) AP-MS upon infection
with chromosomally tagged effector strains in epithelial and macrophage cell lines, respectively [55].
In this study, Walch et al. described 412 novel candidate EH-PPIs, next to 25 previously observed
interactors, of which 4 SifA and 16 PipB2 EH-PPIs were in accordance with the study of D’Costa and
colleagues. Remarkably, only 28 EH-PPIs were identified in both cell lines studied, putatively evincing
the different infection strategies used by STm in epithelial cells and macrophages in addition to the
differential host protein expression profiles of both cell lines. Furthermore, several EH-PPIs, such as
SifA with VPS39 and RBM10, were uniquely found after crosslinking before pulldown, suggestive
of transient or weak EH-PPIs. In plants, several AP-MS-based studies investigating EH-PPIs have
been performed [56–59]. A commonly used practice is GFP-trapping in which a translational fusion
between the protein of interest and GFP is used to coprecipitate interacting proteins using beads
coupled to an anti-GFP antibody. Using this technique, Sang et al. showed that the R. solanacearum T3E
RipAY targets thioredoxins, proteins involved in redox regulation, of tobacco and Arabidopsis [59].
Furthermore, Üstün et al. showed that the P. syringae T3E HopM1 interacts with different proteasomal
proteins of tobacco, including ECM29, which, interestingly, is involved in halting proteasomal protein
degradation [59,60].
Table 1. Overview of type-III effectors host targets identified using AP-MS. Host interactors indicated
with an asterisk were validated using co-immunoprecipitation. Underlined host interactors were found
in multiple independent interactomics studies.
Bacterial
Pathogen Type-III Effector
(Candidate) Host
Interactors (Gene Names)
Proteomics
Approach
Species or Cell
Type Ref.
Pseudomonas
syringae
HopF2 AHA2, AHA11, PDR8/PEN3, ERD4, PIP2A, PIP3, Clathrinheavy chain, ADP/ATP Carrier protein, REM1.3, HIR2 AP-MS Arabidopsis [56]
HopM1
UPL1, UPL3, ECM29, proteins related to 26S proteasome
non-ATPase regulatory subunits 2, 3, 6, 12, 14, BIG,
orthologues of AtMIN7 and AtMIN10
AP-MS
(GFP-trap) Tobacco [57]
HopQ1 TFT1*, TFT2, TFT3, TFT4, TFT5*, TFT6, TFT7, TFT9, TFT10 AP-MS Tomato (cv.Moneymaker) [58]
Ralstonia
solanacearum RipAY NbTRX-h11, NbTRX-h09, NbTRX-h10, NbTRX-h15*
AP-MS
(GFP-trap)
Tobacco and
Arabidopsis [59]
Chlamydia
trachomatis
58
Inc-class effectors 354 high-confident PPIs AP-MS HEK293T [48]
Citrobacter
rodentium
EspT HSPD1
AP-MS
(in vitro)
RAW 264.7 and
HeLa lysates [51]
NleA LDHB, PHGDH, SEC24B, DLG1, SEC23A, SLC3A2
NleG1 TUFM, GAPDH, UQCRC2, PKM, MCM7, PRKDC, CPS1,SLC25A6, SLC25A5, SERPINH1, PHGDH, ACADM
NleK HNRNPM
Salmonella
enterica serovar
Typhimurium
SopB CDC42
AP-MS
(SILAC)
HEK293T [61]
SspH2 SUGT1*, AIP, BUB3*, YWHAG, BAG2
SseJ RHOA, RHOC
SspH1
PKN1
PKN1* AP-MS RAW 264.7 andHeLa lysates [51]
SseG DSP, CAPRIN1 AP-MS(SILAC) HEK293T [62]
MYH10, IPO5, PHB2, MYL12B, EPHX1, RANBP6, EIF3B,
NNT, SDHA, EIF3A, VDAC1, OCIAD1, NDUFA13,
FAM162A, ARL6IP5, GK, API5, EIF3E, COX5B, VDAC2,
PSMD12, RAB8A, AP3D1, AGK, CLPTM1L, CUL4B,
VAMP3, BAX, CYP51A1, HMOX2, RDH11, TMEM48
AP-MS HEK293T [52]
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Bacterial
Pathogen Type-III Effector
(Candidate) Host
Interactors (Gene Names)
Proteomics
Approach
Species or Cell
Type Ref.
SseL
OSBPL1A*, TLN1 AP-MS(SILAC) HEK293T [63]
NEDD8, TXN, PSME2, S100A6, RCC2, S100A11, PRDC1,
UBA52 AP-MS
RAW 264.7 and
HeLa lysates [51]
SseF JUP AP-MS(SILAC) HEK293T [62]
RBM10, THRAP3, ARGLU1 AP-MS HEK293T [52]
GogA PRPF31
AP-MS
RAW 264.7 and
HeLa lysates [51]
GtgA
MOGS, SLC25A11, PTGES2, SSR1, ATP5O, USMG5,
GPNMB, BCAP29, ALDH3B1, 1700055N04RIK, RPN2,
HADHA, YME1L1, ABHD12, IQGAP1, GALNT7, SGPL1,
HSD17B12, CYC1, SLC25A12, SLC25A13, ACSL4, GM10250,
B4GAINT1, LRRC59
GtgE LYN, GOPC
SpvC LPXN
SrfH
DNAJA1, ABCF2, ERK2*, UPF1, PFKI, MSH2, GM9755,
SUCLG1, GALK1, GRPEL1, ACADM, PFKP, EPRS, IDH3B,
SLC25A12
SssB GRN
SifA MYH10, MYL6, MYL12B, EIF3B, RBM10, HM13, EIF3A,CDIPT, EIF5AL1, AP3D1, NDUFA13, TMEM59, ATP5D
AP-MS HEK293T [52]PipB2
GCN1L1, XPO1, IRS4, MYH10, FANCI, XPO5, ATP2B1,
FKBP5, SUGT1, NCAPD2, MYH9, SCRIB, KIAA0368,
TNPO1, LRRC1, TELO2, DIS3, ACTA1, DDX19A, AP3D1,
PDS5A, MMS19, HDDC2, MYL12B, CAND2, NTPCR,
RHOG, TRMT1, CDC73, YTHDF2, RDH11, ANXA4, PELO,
UMPS, PRPF6, NAA15, PSMD12, MTHFD1L, EEF1E1,
ADCK3, PLAA, CALM2, UROD, ANP32E, FABP5, LTN1,
MLF2, SYNE1, ATP6V1H, CUL1, NEDD8-MDP1, FBXO22,
SNRPG, UBXN1, AUP1, PIN1, LYPLA2, ARIH1, PCID2,
LARP4B, CELF1, ARGLU1, GOLPH3, ORC3, DDX23
SopD2
MYH10, MYL6, MYL12B, MYH9, RBM10, RAB10, EIF3B,
CYFIP1, PHB2, EIF3A, AP2B1, EIF3E, AP3D1, MYO1B,
RAB8A, AP3B1, AP2A1
SopA a
TRIM56*, TRIM65*, HDAC10, GSTM3, PCMT1, MAPK3,
AP2B1, XRCC5, PPP2R2A, XRCC6
AP-MS
(SILAC;
GFP-trap)
HeLa
[63]
TRIM56*, TRIM65*, EPS15L1, GTF2F2, PDLIM7, CSTF1,
GTF2F1, RAD23B, MAPRE1, G6PD
AP-MS
(SILAC) HCT116
15 STm T3Es 446 high-confident PPIs
AP-MS
(delivery of
chromosomally
tagged T3Es in
the context of
infection)
HeLa and RAW
264.7 [55]
EPEC
Map NERF2
AP-MS
(SILAC) HEK293T
[64]
EspJ WDR23
EspL MAP7*
EspX MAP7
NleA SEC23A, SEC24B, DLG1
NleB1 MAP7*
NleC P300
EspZ CD98*, RPS27A, HSP90AB1, HSP90AA1 AP-MS(SILAC) HEK293 [61]
a only the ten most significant SopA-enriched hits are listed. Candidate host interactors indicated in bold were also
found using BioID (see Table 2).
Various examples exist in which SILAC coupled with IP-MS was capable of pinpointing EH-PPIs
upon mammalian host cell T3E expression or addition of the recombinant T3E to cell lysates [61–67].
This way, Shames et al. described the function of EspZ and NleC EPEC effectors by unravelling their
interaction with host target CD98 and p300, respectively [62,63]. Direct interactions of both effectors to
their corresponding host prey were confirmed by co-IP. Another study investigated the interaction
partners of SPI-2 effectors in mammalian cells [64] and identified previously reported binding partners
for SopB, SseJ (Salmonella secreted effector protein J), and SspH1 (Salmonella secreted protein H1).
Besides, several new interactions were presented, such as junction plakoglobin and desmoplakin as
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host target of the less characterized effectors SseF and SseG, respectively. Furthermore, EH-PPIs for
SseL with oxysterol-binding protein 1 (OSBP) and SspH2 with SUGT1 (Suppressor of G2 allele of SKP1
homolog) were verified. By means of co-IP and in the context of a stable inducible SopA-expressing
cell line as well as Salmonella-infected cells, Fiskin and co-workers validated the interaction between
SopA and two significant SopA-enriched hits, namely tripartite motif containing 56 (TRIM56) and
TRIM65 [65].
2.2. Proximity-Dependent Labeling Approaches
In contrast to the previously discussed methods, proximity-dependent labeling approaches
also capture proximal proteins besides direct and indirect PPIs. Use of a promiscuous biotin
ligase (PBL) or a peroxidase (e.g., APEX (ascorbate peroxidase)) fused to a bait of interest enables
covalent biotin labeling of vicinal proteins, and thus does not require the interaction of the protein
complex to be maintained during purification or isolation, the latter being a major improvement
considering that the use of different stringencies of (washing) buffers to extract proteins and remove
nonspecific binders in AP-MS can heavily impact the proteins retained when performing affinity
purifications. Following protein digestion, biotinylated proteins can subsequently be identified by
means of LC-MS/MS. In proximity-dependent biotinylation (PDB; Figure 2), identification of protein
interactors and proximal proteins is based on the enzymatic action of a PBL, an approach referred
to as BioID when making use of mutant E. coli BirAR118G, designated BirA* (R118G), as PBL [68].
More specifically, upon supplementation of biotin to cells expressing a BioID fusion protein, the PBL
moiety transfers activated biotin, or biotinoyl-AMP, to accessible primary amines in its vicinity [69].
This enables subsequent streptavidin-based purification and MS-based identification, overall permitting
the identification of high as well as low affinity interactions. The robust biotin-streptavidin interaction
permits the use of stringent washes (e.g., high content of (chaotropic) salts and detergents) and
thus results in a reduced background of nonspecific proteins bound to affinity resins—providing
significant improvements over AP-MS. Additionally, the ability for selective capture makes the method
generally insensitive to protein solubility or protein complexation, and thus improves its applicability
for interactome analysis of membrane proteins and cytoskeletal constituents, representing major
advantages over alternative interactomics approaches. Occasionally, the relatively large BioID tag
(35.3 kDa) may affect subcellular targeting of certain bait proteins. To steer its observed cytosolic
localization in eukaryotic cells, BirA* can be engineered with a signal leader peptide to translocate
the fusion protein to the desired compartment [70,71]. To potentially improve on these aspects,
Kim and colleagues developed a smaller (27 kDa) second-generation PBL, called “BioID2”, from the
Aquifex aeolicus biotin ligase, naturally lacking a DNA-binding domain [72]. Likewise, the Khavari lab
engineered a mutant biotin ligase from Bacillus subtilis termed BASU (28 kDa) [73]. More challenging,
however, is the relatively slow kinetics of these first- and second-generation enzymes used for PDB
as sufficient biotinylation typically requires up to 16 to 24 h of labeling, overall complicating the
exploration of dynamic interactions. To tackle the latter inadequacy, third-generation PBLs were
developed by the directed evolution of BioID in yeast, namely TurboID (35 kDa) and miniTurbo
(28 kDa) [74]. Alternatively, in vitro BioID (ivBioID) was shown to capture dynamic interactions by
PBL labeling of permeabilized fixed cells, obtaining the cellular context in a physiologically inactive
state and thus partially overcoming the limitation of slow BirA* kinetics while additionally increasing
the spatial resolution [75].
BioID made its first introduction in planta in 2017 where researchers used rice protoplasts to
investigate the vicinal proteins of OsFD2, a rice transcription factor, tagged with BirA* [76]. In 2018,
Khan et al. applied the technique for identifying EH-PPIs in a whole plant system (transgenic
A. thaliana) by searching for interactors of the P. syringae T3E membrane-associated HopF2 (Table 2) [77].
Interestingly, when compared to acquired AP-MS data showing the interaction of HopF2-HA with
10 membrane-associated proteins [56], nine extra membrane-associated prey proteins could be identified
with BioID (i.e., 18/19 of the proximal proteins identified localized to membranes), thereby revealing
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some previously unknown targets of HopF2. Although 58% (11/19) of the strong HopF2 interactors
identified by BioID were also identified with AP-MS, a few known interactors of HopF2 (MKK5, BAK1)
were missed with BioID, a finding likely attributed to the non-accessible nature of free amines on
proximal proteins for biotinylation, an observation in line with other reports [72,78]. Using BioID
in tobacco leaves, researchers identified five proximal plant proteins to interact with the P. syringae
T3E AvrPto, including RIN4 which functions at the membrane and is involved in immunity [79].
Largely due to the insufficient compatibility of using first- and second-generation PBLs of bacterial
origin in plants, it was only with the introduction of the third-generation enzymes such as Turbo and
miniTurbo, working optimally at temperatures far below 37 ◦C, that PBL became more proficient
in identifying PPIs in planta [80–82], making BioID amenable to boost bacterial effector biology research
in the context of plant hosts in the future.
Table 2. Overview of type-III effectors host targets identified using proximity labeling. Host interactors
indicated with an asterisk were validated using co-immunoprecipitation.
Bacterial Pathogen Type-IIIEffector
(Candidate) Host
Interactors (Gene Names)
Proteomics
Approach
Species or Cell
Type Ref.
Pseudomonas syringae
HopF2
19 a
RIN4, REM1.3, PCAP1, PHOT1, PHOT2, SYP122, PMI1,
PATL1, PATL2, RBCS1A
BirA* Arabidopsis [77]
AvrPto 25
a
RIN4, APK1, APK2, TOM1, APP4* BirA* Tobacco [79]
Chlamydia psittaci
SINC 22
a
ELYS, laminB1*, emerin*, MAN1, LAP1, LBR BirA* HeLa [83]
IncF
13 a
LRRF1, MAP1B, CYTB, BASP1, YWHAH, MARCKS,
YWHAB, K1C20
APEX2 HeLa [84]IncATM
18 a
LRRF1, MAP1B, CYTB, BASP1, MYPT1, TERA, MAP4,
PUR6, SNX1, SRC8, MEP50, SNX6, PLIN3, IF4B, NDKA,
NDKB
IncA
192 a
LRRF1, MAP1B, CYTB, BASP1, MYPT1, TERA, MAP4,
PUR6, SNX1, SRC8, MEP50, SNX6, PLIN3, IF4B, NDKA,
NDKB, YWHAH, MARCKS, YWHAB, K1C20
Salmonella enterica
serovar Typhimurium
SifA
167 b
BLOC-2*, IRS4, EPB41L3, EPB41L2, MLLT4, DST, LBR,
YKT6, TMPO, SLC12A2
BirA* HEK293T [52]
PipB2
149 b
KIF5B, EPB41L3, IRS4, TMPO, LEMD3, EPB41, MLLT4,
KLC1, EPB41L2, KLC2
SseF
107 b
TUFM, IRS4, LBR, EPHA2EPB41L2, UBB, DDX17, CKAP4,
PTPLAD1, HNRNPC
SseG
145 b
TMPO, ESYT1, LBR, PGRMC2, LEMD3, CKAP4, ABCD3,
RPN1, ACSL3, LMAN1
SopD2
61 b
RUVBL1, RUVBL2, HSP90AA1, CCT2, CLCN7, SUGT1,
RAB7A, YKT6, ZFYVE16, HNRNPAB
a hits listed are top candidates selected by the researchers. b only the ten most significantly enriched hits are listed.
Candidate host interactors indicated in bold were also found using AP-MS (see Table 1).
An alternative proximity labeling (PL) approach, relies of the translational fusion of engineered
APEX to biotinylate proteins in the vicinity of the bait [85]. In the presence of H2O2, APEX catalyzes
the oxidation of biotin-phenol to the highly reactive and short-lived biotin-phenoxyl radical
that subsequently reacts with electron-rich amino acids (>98% tyrosine and <2% tryptophan,
cysteine [86]) of proximal proteins in a range of ~20 nm [86], resulting in their biotinylation. As for
third-generation PBLs, a more efficient version of the enzyme was generated, i.e., APEX2, using directed
evolution [87]. APEX(2)-based proximity labeling greatly excels in terms of labeling time compared to
BioID/BioID2/BASU (1 min or less vs. >16 h) and thus even the labeling kinetics of the recently realized
TurboID and miniTurbo PBLs (~10 min of labeling). APEX2 has enabled the study of time-sensitive
protein complexation, such as G-protein-coupled receptor signaling [88,89]. Because of its toxicity,
the use of H2O2 however warrants caution and its use is unsuitable in case of high endogenous
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peroxidase activity, therefore making TurboID and miniturbo the strategies of choice for non-toxic
proximity labeling [80,90].
Overall, PL has already proven to be a potent tool to uncover eukaryotic PPI networks [91,92],
next to defining subcellular or localized protein compositions [93]. In bacterial cells, proximity
labeling was only implemented very recently using the advantageous kinetics of APEX2-dependent
biotinylation thereby revealing proteins involved in biogenesis of the type VI secretion system (T6SS) in
E. coli [94]. By stalling the T6SS assembly pathway at different stages, Santin and co-workers were able to
pinpoint the consecutive proximal partners of TssA during T6SS assembly. The first report on EH-PPIs
mapping using BioID was in a study aiming at the identification of host targets of the newly discovered
Chlamydia psittaci (C. psittaci) T3E SINC [84]. BioID revealed that SINC targeted the host nuclear
envelope, thereby contributing potential vital knowledge of C. psittaci virulence. More recently, BioID
was successfully applied as a large-scale screening method for the discovery of Salmonella T3E-host
protein interactions [53]. D’Costa and colleagues screened the Salmonella effectors SopD2, SifA, PipB2,
SseF and SseG for human protein interactors using inducible BioID effector fusions expression in stable
HEK293T epithelial cell lines. The presence of an additional FLAG-tag enabled the application of
BioID and AP-MS in parallel. Using BioID, eight known besides 632 putative novel (indirect) EH-PPIs
were identified, the latter category showing a significant enrichment of membrane proteins and
proteins implicated in vesicle organization-, cytoskeleton-, and endosomal transport when compared
to AP-MS data. Five of the newly discovered candidate EH-PPIs were validated through co-IP in
the case of SifA, including the interaction with the host multi-subunit BLOC-2 complex implicated
in lysosomal trafficking, a complex not picked up by traditional AP-MS. In addition, since bacterial
effectors notoriously target biological membrane (-associated) complexes [95], this study underscores
the utility of BioID and PL in general in elucidating bacterial EH-PPIs and further illustrates the value
of robust high-throughput screening platforms in increasing our understanding of effector biology.
2.3. Virotrap
By allowing stringent IP conditions or the direct identification of biotinylated sites [96],
BioID benefits from the covalent biotin modification to circumvent false positive or negative PPIs due
to cell lysis and nonspecific interactions [87]. Conversely, Virotrap eliminates the need for cell lysis
altogether by making use of the vesicle-forming properties of the human immunodeficiency virus
type 1 (HIV-1) GAG protein (55 kDa) [97]. Expression of an N-terminally GAG-tagged bait results
in the budding of so-called virus-like particles (VLPs)—wherein interacting proteins are “trapped”.
Important for downstream purification of these VLPs, is the co-expression of vesicular stomatitis
virus G protein (VSV-G) in both the FLAG-tagged and untagged form (i.e., expression of both forms
facilitate trimerization). VSV-G(-FLAG) appears as a composite trimer at the cell membrane and
consequently, after budding, makes up part of the VLP surface. As a result, VLPs can simply be isolated
from the growth medium using immobilized anti-FLAG antibodies. Next, VLP contents are liberated
and typically analyzed using label-free shotgun proteome analysis. It should be noted that natural
GAG protein is thought to reside in the cytosol before multimerization at the plasma membrane,
at multivesicular bodies or at similar surfaces [98]. Hence, the endogenous location of Virotrap
bait-interactions should preferentially be the cytosol, as this is the most physiologically relevant
location for interactions in Virotrap. Currently, studies on 33 Virotrap target hits [98,99] that reside
in or at the plasma membrane or fulfill (one of) their function(s) in the cytosol have been published.
To date, Virotrap has only been optimized in HEK293T cells. Nonetheless, with certain
optimizations, Virotrap would likely be applicable to other mammalian cells and can thus potentially
be extrapolated to other species. In this context, it is noteworthy that VLPs have successfully been
isolated from plant tissue expressing full-length HIV-1 GAG [100], so application of Virotrap in plants
could be an interesting subject of future investigation. Virotrap has fruitfully assisted in selecting
candidate interactions for human ring finger protein 41 (RNF41) and proved to be orthogonal to
BioID and AP-MS in that regard [97,99]. Furthermore, we recently obtained proof-of-concept data
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that Virotrap can be used for studying EH-PPIs by fusing the C-terminus of GAG to Salmonella T3Es,
by the identification of known host interactors (unpublished data). With respect to its complementarity
to other high-throughput methods, we anticipate that Virotrap will further aid the comprehensive
discovery of EH-PPI maps.
3. Discussion
The availability of various interactomics approaches and their application have provided insights
into the strengths and weaknesses with respect to studying host-pathogen interactions. The often
complementary nature of the different interactomics methods currently at hand, stresses the need to use
more than one approach to obtain a complete and less biased picture of EH-PPI repertoires (Figure 3),
as illustrated by several studies discussed above [99,101,102]. AP-MS and derived technologies
thereof are usually not successful in detecting weak and dynamic PPIs, due to their highly dynamic
nature, or membrane targets, due to their poor solubilization and thus extraction during native
protein extraction.
The development of techniques such as BioID and Virotrap (partially) alleviated these shortcomings
by means of covalent modification and avoiding cell lysis, respectively [91,97]. More specifically,
BioID on the one hand takes advantage of marking PPIs by means of the covalent attachment of biotin,
a stable modification that is retained during cell lysis conditions, opposed to the necessity for the
maintenance of interactions upon cell lysis in case of AP-MS analysis. Virotrap on the other hand benefits
from its unique feature being the evasion of cell lysis by hijacking vesicle-forming properties of HIV-1
GAG protein. In addition, especially for poorly soluble proteins, such as membrane and cytoskeletal
proteins, BioID and Virotrap have proven to clearly outperform AP-MS screenings [97,99,101,102].
Since the total amount of membrane-associated effectors is estimated to be around 30%, there is a clear
necessity for techniques capable of targeting this protein category [95]. BioID takes the identification of
PPIs a step further by identifying the so-called “proxeome”, inevitably however making selection of
direct effector–host targets relevant for effector function a more laborious task. Selection of appropriate
controls and linkers may facilitate and streamline downstream validation efforts [72,103]. GFP fused
to a PBL, for example, has frequently been used as a control for non-bait specific biotinylation [83].
In addition, Virotrap has proven to be complementary to BioID in identifying PPIs [99], and both
techniques are based on a completely different principle, making the methods also intrinsically
complementary. Although both techniques deliver only partially overlapping protein identifications,
they also harbor a specific set of missing interactions, or false negatives. For instance, proteins lacking
an (accessible) lysine cannot be biotinylated and will not be perceived in case of BioID. Proteins that
are too distant from the BioID tag will also be missed. The latter can potentially be overcome by
incorporating a (longer) linker between the tag and the bait, which, in addition, reduces the effects of
steric hindrance (Figure 4) [73], or alternatively, by re-positioning of the PBL. False negative interactions
in Virotrap might include proteins residing in confined subcellular structures of organelles, such as
the nucleus, or protein complexes too large to fit in the VLP particles estimated to be 100 to 350 nm
in diameter [104]. False positives can to a certain extent be limited by an appropriate experimental
design. Endogenously biotinylated proteins, for instance, can easily be filtered out by comparison
with a control dataset representing the background. False positive interactions with GAG can be
eliminated by comparing to a control setup. An appropriate VLP control setup, i.e., a representation of
the complete VLP proteome in absence of the effector, is indispensable for Virotrap MS-based analysis
as VLPs exhibit their own characteristic proteome content [97]. In the context of appropriate BioID
controls, it is noteworthy that by using the power of genome editing, Vandemoortele et al. designed
a method to obtain isogenic cell lines expressing T2A-BirA* bait fusion or its corresponding BirA*
control protein, both under the control of the endogenous bait promoter [105]. The method relies
on introduction of the T2A-BirA* cassette at the C-terminus of the protein of interest resulting in
bicistronic expression of both the bait and BirA*, thereby serving an elegant control setup for isogenic
cells obtained by targeting of a Cas9 enzyme, fused to a cytidine deaminase to the T2A autocleavage
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site, thereby inactivating the T2A peptide sequence resulting in the expression of the bait fusion
from its endogenous promoter. It is clear that EH-PPI discovery is multifaceted and requires careful
assessment of the effector protein under investigation to set up a successful experiment. The study of
effector biology is further complicated by the range of susceptible hosts. Therefore, selection of an
appropriate host context is of essential importance, also viewing the reported overreliance on a few
popular models clearly biasing host-pathogen interactomics studies [106]. We recently demonstrated
that EH-PPIs of bacterial root pathogens can be studied when making use of hairy root cultures closely
mimicking the environment of the natural host [107] (unpublished data). In this setup, roots are
transformed with Agrobacterium rhizogenes carrying the desired construct of for example a tagged
effector. Transformed roots can be selected for (e.g., by co-expression of a fluorescent marker) and
used as model for protein interaction studies [83]. It is also important to consider the mode of effector
tagging. Of note, signal peptides, CBDs and for instance GTP-activating domains typically reside at
the N-terminus of bacterial effectors [108]. The latter suggests a general preference for C-terminally
tagged effector fusions to retain functionality, but it is always essential to validate functionality of the
tagged variant independent of tag size.Int. J. Mol. Sci. 2020, 21, 6891 15 of 24 
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secreted by Salmonella, i.e., when SifB is present at physiological levels, a cytoplasmic localization was 
observed upon heterologous (over-)expression [112]. Of note, the lack of EH-PPI identifications for 
some effectors studied by Sontag et al. could be due to improper effector production or localization, 
or the absence of specific cofactors or protein modifications in vitro. Moreover, many effectors rely 
on protein modifications or the expression of other effectors on which their function relies. EPEC Tir 
(translocated intimin receptor) phosphorylation (Y454), for example, leads to recruitment of N-
WASP, resulting in actin assembly at the site of bacterial invasion [113]. The T3E SopD from STm 
relies on the phosphatase activity of a second T3E SopB for its targeting to the plasma membrane 
[114]. As such, effectors are preferably studied upon native delivery in infection(-relevant) 
conditions. One way is to make use of bacteria encoding endogenously tagged effectors when 
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P = protein interactor (direct/indirect); red and dotted circles represent post-translational modification
and weak or dynamic interactors, respectively.
Investiga ion of bacterial effectors in their physiological cont xt can be essential for proper
effector functioning. This is for instance demonstrated by the observed aberrant localization of certain
heterologously expressed effectors versus the localization of effectors delivered through the bacterial
secretion system by infection of host cells, whether or not following endogenous chromosomal
tagging [109,110] or over xpr ssio in bact ria [111]. I lustrative of this, while S fB is known to be
targeted to the Salmonella-containing vacuole (SCV) and Salmonella-induced filaments (Sifs) when
secreted by Salmonella, i.e., when SifB is present at physiological levels, a cytoplasmic localization was
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observed upon heterologous (over-)expression [112]. Of note, the lack of EH-PPI identifications for
some effectors studied by Sontag et al. could be due to improper effector production or localization,
or the absence of specific cofactors or protein modifications in vitro. Moreover, many effectors rely
on protein modifications or the expression of other effectors on which their function relies. EPEC Tir
(translocated intimin receptor) phosphorylation (Y454), for example, leads to recruitment of N-WASP,
resulting in actin assembly at the site of bacterial invasion [113]. The T3E SopD from STm relies on the
phosphatase activity of a second T3E SopB for its targeting to the plasma membrane [114]. As such,
effectors are preferably studied upon native delivery in infection(-relevant) conditions. One way is to
make use of bacteria encoding endogenously tagged effectors when infecting host cells. A potential
strategy based on BioID would be to tag effectors with a PBL at their endogenous locus (endogenous
BioID, eBioID, Figure 4). Secretion of tagged T3Es and T4Es have been proven successful in case of small
tags and certain reporters [109,111,115]. However, viewing the limited unfolding capacity of the T3SS
(or T4SS [116]) and the stable β-barrel structure of fluorescent proteins (e.g., GFP), fusion of fluorescent
proteins to T3Es was shown to block T3SS-mediated secretion [13], thereby generally excluding the use
of tightly folded proteins as T3E fusions. However, a split GFP system was developed that enables
GFP-IP and real-time imaging of effector translocation. By tagging the effector with strand 11 from GFP
and expressing the other ten strands in the desired host cell, delivery, and localization of, for instance,
three STm effectors (i.e., PipB2, SteA and SteC) [109] and two R. solanacearum GMI1000 effectors
(i.e., AvrB and PopP2) was successfully accomplished [117]. Alternatively, other modules with likely
higher unfolding capacity as compared to GFP, such as PhoA, calmodulin-activated adenylate cyclase
and beta-lactamase, have been successfully used to monitor effector secretion [118–120]. Upon native
delivery of tagged effectors, and to improve the resolution of future host-pathogen interactomics
studies, it will be increasingly important to additionally consider spatiotemporal effector expression
profiles and kinetics of effector delivery. As illustrated by the Knodler et al. study profiling T3E-host
PPIs at later stages of infection (i.e., 20 hpi), a bias towards the identification of Salmonella SPI-2 T3Es
host targets compared to SPI-1 targets could clearly be observed. This discrepancy is largely due to the
fact that SPI-2 T3Es are translocated at later stages of infection when bacterial loads are high, implying
their generally higher abundance and concomitant improved detectability of SPI-2 host targets [56].
The implementation of high sensitive data-independent acquisition (DIA)-based proteomics approaches
shown to outperform data-dependent acquisition (DDA) workflows in identifying and quantifying
low abundant proteins, may aid future EH-PPI studies of low abundant effectors [121]. All considering,
it should be attempted to closely mimic real infection conditions, but a delicate balance between
accuracy and feasibility is ultimately essential.
Creative approaches using the combined power of AP-MS and BioID have enabled diversion of
relative spatial distances for proteins within a complex [101,122]. Liu et al. introduced this principle
using a MAC-tag (StrepIII-BirA*), enabling the integration of stoichiometric complexation information
from AP-MS with the identification of transient or proximal interactions by BioID. D’Costa et al.
also used a composite tag, but used it to perform both methods in parallel (enabling the comparison of
identical (tagged) baits besides reducing cloning efforts) [53].
Furthermore, it is important to consider that effectors with enzymatic activity might not form
stable interactions with their substrates and that protein interactions with other macromolecules,
such as lipids or DNA/RNA, should not be disregarded when considering pathogenesis mechanisms.
Substitution of the described methodologies by other technologies to frame these interactions is
thus desirable. Interestingly, BASU was recently reported to capture RNA-protein interactions using
labeling times as short as 1 min [123].
Implementing complementary MS-based strategies was proven very useful in distinguishing
background from relevant PPIs. Integration of these rich host-pathogen interactomics datasets with
knowledge of timing of effector expression, secretion, activity and (subcellular) localization will
eventually enable us to shed better lights on bacterial pathogenesis.
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